Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (22.660)

91

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine : a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2024

von Oda, Y. | Kumagai, Y. | Kanai, M. | +8

92

Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency : Results from REAL4, a phase 3 clinical trial

enthalten in: Clinical endocrinology | 2024

von Mori, J. | Ohata, Y. | Fujisawa, Y. | +5

93

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

94

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer : a multicenter, open-label, randomized, controlled, phase 3 trial

enthalten in: Signal transduction and targeted therapy | 2024

von Pan, Q. | Zhao, J. | Liu, L. | +27

95

KESTREL and KITE Phase 3 Studies : 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

enthalten in: American journal of ophthalmology | 2024

von Wykoff, C. | Garweg, J. | Regillo, C. | +12

96

Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study) : a French multicenter randomized phase III study

enthalten in: Journal of neurosurgery | 2024

von Picart, T. | Pallud, J. | Berthiller, J. | +33

97

Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension

enthalten in: Epilepsia open | 2024

von Nishida, T. | Lee, S. | Inoue, Y. | +5

98

Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density : A Secondary Analysis of a Phase 3 Randomized Controlled Trial

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Roy, S. | Malone, S. | Sun, Y. | +8

99

FDA Approval Summary : Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Woods, A. | Norsworthy, K. | Wang, X. | +9

100

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27